Latest News

Novavax starts Phase III Covid-19 vaccine trial in U.K.

The company, which also published Phase I data from its Phase I/II study earlier this month, is enrolling 10,000 volunteers aged 18 to 84 for the placebo-controlled trial of the vaccine against SARS-CoV-2, NVX-COV2373.

Source link

Related posts

Opinion: Rep. Joe Kennedy III: It’s time to legalize marijuana at the federal level


Can a lack of food access lead to obesity?


Detection of Cross-Correlation between Gravitational Lensing and gamma Rays


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World